Located in Sant Cugat del Vallès (Barcelona, Spain), the facility produces and packs Respimat, an inhaler for administering the drugs marketed by Boehringer Ingelheim for patients with asthma and COPD.
With an investment of more than €120 million, the facilities stand on an area of 17,000 sqm divided into production areas, laboratories, a warehouse, offices and technical areas.
For Boehringer, the Respimat plant’s methodology and processes are an example of the latest industry innovations, the gamut from serialisation and aggregation processes, and electronic manufacturing guides.
The manufacturing equipment includes technologies specific to Industry 4.0, such as digitalisation, systems integration, robotics, and a high level of automation. Furthermore, the plant meets the highest quality and environmental protection requirements.